Islet Function and Insulin Secretion

Textbook of Diabetes: Fourth Edition

Volumn , Issue , 2010, Pages 85-103

  Jones, Peter M ^a   Persaud, Shanta J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Gastrin releasing polypeptide (GRP); Glucose dependent insulinotropic peptide (GIP); Hydroperoxyeicosatetrenoic acids (HPETES); Hydroxyeicosatetrenoic acids (HETES); Pituitary adenylate cyclase activating polypeptide (PACAP); Protein kinase C (PKC); Vasoactive intestinal polypeptide (VIP)

Indexed keywords

EID: 84886060133     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444324808.ch6     Document Type: Chapter

References (133)

1. Langerhans P. Beitrage zur mikroskopischen Anatomie der Bauchspeicheldruse. Inaugural dissertation, Gustav Lange ed. 1869.
2. Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 2006; 103: 2334-2339.
3. Bonner-Weir S. Anatomy of the islet of Langerhans. In: Samols E, ed. The Endocrine Pancreas. New York: Raven Press, 1991; 15-27.
4. Nyman LR, Wells KS, Head WS, McCaughey M, Ford E, Brissova M, et al. Real-time, multidimensional in vivo imaging used to investigate blood flow in mouse pancreatic islets. J Clin Invest 2008; 118: 3790-3797.
5. Ahren B. Autonomic regulation of islet hormone secretion: implications for health and disease. Diabetologia 2000; 43: 393-410.
6. Winzell MS, Ahren B. Role of VIP and PACAP in islet function. Peptides 2007; 28: 1805-1813.
7. Halban PA, Wollheim CB, Blondel B, Meda P, Niesor EN, Mintz DH. The possible importance of contact between pancreatic islet cells for the control of insulin release. Endocrinology 1982; 111: 86-94.
8. Halban PA, Powers SL, George KL, Bonner-Weir S. Spontaneous reassociation of dispersed adult rat pancreatic islet cells into aggregates with three-dimensional architecture typical of native islets. Diabetes 1987; 36: 783-790.
9. Hopcroft DW, Mason DR, Scott RS. Insulin secretion from perifused rat pancreatic pseudoislets. In Vitro Cell Dev Biol 1985; 21: 421-427.
10. Carvell MJ, Persaud SJ, Jones PM. An islet is greater than the sum of its parts: the importance of intercellular communication in insulin secretion. Cellscience Rev 2006; 3: 100-128.
11. Ravier MA, Guldenagel M, Charollais A, Gjinovci A, Caille D, Sohl G, et al. Loss of connexin 36 channels alters beta-cell coupling, islet synchronization of glucose-induced Ca 2+ and insulin oscillations, and basal insulin release. Diabetes 2005; 54: 1798-1807.
12. Serre-Beinier V, Bosco D, Zulianello L, Charollais A, Caille D, Charpantier E, et al. Cx36 makes channels coupling human pancreatic beta-cells, and correlates with insulin expression. Hum Mol Genet 2009; 18: 428-439.
13. Carvell MJ, Marsh PJ, Persaud SJ, Jones PM. E-cadherin interactions regulate beta-cell proliferation in islet-like structures. Cell Physiol Biochem 2007; 20: 617-626.
14. Jaques F, Jousset H, Tomas A, Prost AL, Wollheim CB, Irminger JC, et al. Dual effect of cell-cell contact disruption on cytosolic calcium and insulin secretion. Endocrinology 2008; 149: 2494-2505.
15. Konstantinova I, Nikolova G, Ohara-Imaizumi M, Meda P, Kucera T, Zarbalis K, et al. EphA-Ephrin-A-mediated beta cell communication regulates insulin secretion from pancreatic islets. Cell 2007; 129: 359-370.
16. Van Schravendijk CF, Foriers A, Hooghe-Peters EL, Rogiers V, De MP, Sodoyez JC, et al. Pancreatic hormone receptors on islet cells. Endocrinology 1985; 117: 841-848.
17. Hauge-Evans AC, King AJ, Carmignac D, Richardson CC, Robinson IC, Low MJ, et al. Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 2009; 58: 403-411.
18. Ravier MA, Rutter GA. Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic alpha-cells. Diabetes 2005; 54: 1789-1797.
19. Persaud SJ, Muller D, Jones PM. Insulin signalling in islets. Biochem Soc Trans 2008; 36: 290-293.
20. Kitsou-Mylona I, Burns CJ, Squires PE, Persaud SJ, Jones PM. A role for the extracellular calcium-sensing receptor in cell-cell communication in pancreatic islets of Langerhans. Cell Physiol Biochem 2008; 22: 557-566.
21. Detimary P, Jonas JC, Henquin JC. Stable and diffusible pools of nucleotides in pancreatic islet cells. Endocrinology 1996; 137: 4671-4676.
22. Rorsman P, Berggren PO, Bokvist K, Ericson H, Mohler H, Ostenson CG, et al. Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature 1989; 341: 233-236.
23. Rubi B, Ljubicic S, Pournourmohammadi S, Carobbio S, Armanet M, Bartley C, et al. Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J Biol Chem 2005; 280: 36824-36832.
24. Hellman B, Grapengiesser E, Gylfe E. Nitric oxide: a putative synchronizer of pancreatic beta-cell activity. Diabetes Res Clin Pract 2000; 50: S148.
25. Henningsson R, Alm P, Ekstrom P, Lundquist I. Heme oxygenase and carbon monoxide: regulatory roles in islet hormone release-a biochemical, immunohistochemical, and confocal microscopic study. Diabetes 1999; 48: 66-76.
26. Ramracheya RD, Muller DS, Wu Y, Whitehouse BJ, Huang GC, Amiel SA, et al. Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans. Diabetologia 2006; 49: 321-331.
27. Hauge-Evans AC, Richardson CC, Milne HM, Christie MR, Persaud SJ, Jones PM. A role for kisspeptin in islet function. Diabetologia 2006; 49: 2131-2135.
28. Bell GI, Pictet RL, Rutter WJ, Cordell B, Tischer E, Goodman HM. Sequence of the human insulin gene. Nature 1980; 284: 26-32.
29. Hutton JC. Insulin secretory granule biogenesis and the proinsulinprocessing endopeptidases. Diabetologia 1994; 37 (Suppl 2): S48-S56.
30. Andrali SS, Sampley ML, Vanderford NL, Ozcan S. Glucose regulation of insulin gene expression in pancreatic beta-cells. Biochem J 2008; 415: 1-10.
31. Ashcroft SJ, Bunce J, Lowry M, Hansen SE, Hedeskov CJ. The effect of sugars on (pro)insulin biosynthesis. Biochem J 1978; 174: 517-526.
32. Hutton JC. The insulin secretory granule. Diabetologia 1989; 32: 271-281.
33. Hickey AJ, Bradley JW, Skea GL, Middleditch MJ, Buchanan CM, Phillips AR, et al. Proteins associated with immunopurified granules from a model pancreatic islet beta-cell system: proteomic snapshot of an endocrine secretory granule. J Proteome Res 2009; 8: 178-186.
34. Howell SL, Young DA, Lacy PE. Isolation and properties of secretory granules from rat islets of Langerhans. 3. Studies of the stability of the isolated beta granules. J Cell Biol 1969; 41: 167-176.
35. Dunn MF. Zinc-ligand interactions modulate assembly and stability of the insulin hexamer: a review. Biometals 2005; 18: 295-303.
36. Li G, Rungger-Brandle E, Just I, Jonas JC, Aktories K, Wollheim CB. Effect of disruption of actin filaments by Clostridium botulinum C2 toxin on insulin secretion in HIT-T15 cells and pancreatic islets. Mol Biol Cell 1994; 5: 1199-1213.
37. Thurmond DC, Gonelle-Gispert C, Furukawa M, Halban PA, Pessin JE. Glucose-stimulated insulin secretion is coupled to the interaction of actin with the t-SNARE (target membrane soluble N-ethylmaleimide-sensitive factor attachment protein receptor protein) complex. Mol Endocrinol 2003; 17: 732-742.
38. Boyd AE III, Bolton WE, Brinkley BR. Microtubules and beta cell function: effect of colchicine on microtubules and insulin secretion in vitro by mouse beta cells. J Cell Biol 1982; 92: 425-434.
39. Howell SL, Tyhurst M. The cytoskeleton and insulin secretion. Diabetes Metab Rev 1986; 2: 107-123.
40. Howell SL. The mechanism of insulin secretion. Diabetologia 1984; 26: 319-327.
41. Meng YX, Wilson GW, Avery MC, Varden CH, Balczon R. Suppression of the expression of a pancreatic beta-cell form of the kinesin heavy chain by antisense oligonucleotides inhibits insulin secretion from primary cultures of mouse beta-cells. Endocrinology 1997; 138: 1979-1987.
42. Varadi A, Ainscow EK, Allan VJ, Rutter GA. Molecular mechanisms involved in secretory vesicle recruitment to the plasma membrane in beta-cells. Biochem Soc Trans 2002; 30: 328-332.
43. Bai JZ, Mon Y, Krissansen GW. Kinectin participates in microtubule -dependent hormone secretion in pancreatic islet beta-cells. Cell Biol Int 2006; 30: 885-894.
44. Gauthier BR, Wollheim CB. Synaptotagmins bind calcium to release insulin. Am J Physiol Endocrinol Metab 2008; 295: E1279-E1286.
45. Eliasson L, Abdulkader F, Braun M, Galvanovskis J, Hoppa MB, Rorsman P. Novel aspects of the molecular mechanisms controlling insulin secretion. J Physiol 2008; 586: 3313-3324.
46. Gut A, Kiraly CE, Fukuda M, Mikoshiba K, Wollheim CB, Lang J. Expression and localisation of synaptotagmin isoforms in endocrine beta-cells: their function in insulin exocytosis. J Cell Sci 2001; 114: 1709-1716.
47. De VA, Heimberg H, Quartier E, Huypens P, Bouwens L, Pipeleers D, et al. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 1995; 96: 2489-2495.
48. Richardson CC, Hussain K, Jones PM, Persaud S, Lobner K, Boehm A, et al. Low levels of glucose transporters and K + ATP channels in human pancreatic beta cells early in development. Diabetologia 2007; 50: 1000-1005.
49. Van SE. Short-term regulation of glucokinase. Diabetologia 1994; 37 (Suppl 2): S43-S47.
50. Cook DL, Hales CN. Intracellular ATP directly blocks K + channels in pancreatic B-cells. Nature 1984; 311: 271-273.
51. Miki T, Nagashima K, Seino S. The structure and function of the ATP-sensitive K + channel in insulin-secreting pancreatic beta-cells. J Mol Endocrinol 1999; 22: 113-123.
52. Zhang Y, Warren-Perry M, Sakura H, Adelman J, Stoffel M, Bell GI, et al. No evidence for mutations in a putative beta-cell ATP-sensitive K + channel subunit in MODY, NIDDM, or GDM. Diabetes 1995; 44: 597-600.
53. Sakura H, Wat N, Horton V, Millns H, Turner RC, Ashcroft FM. Sequence variations in the human Kir6.2 gene, a subunit of the beta-cell ATP-sensitive K-channel-no association with NIDDM in while Caucasian subjects or evidence of abnormal function when expressed in vitro. Diabetologia 1996; 39: 1233-1236.
54. Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003; 52: 568-572.
55. Sagen JV, Raeder H, Hathout E, Shehadeh N, Gudmundsson K, Baevre H, et al. Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 2004; 53: 2713-2718.
56. Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995; 268: 426-429.
57. Sharma N, Crane A, Gonzalez G, Bryan J, Guilar-Bryan L. Familial hyperinsulinism and pancreatic beta-cell ATP-sensitive potassium channels. Kidney Int 2000; 57: 803-808.
58. Barg S, Ma X, Eliasson L, Galvanovskis J, Gopel SO, Obermuller S, et al. Fast exocytosis with few Ca 2+ channels in insulin-secreting mouse pancreatic B cells. Biophys J 2001; 81: 3308-3323.
59. Jones PM, Persaud SJ, Howell SL. Time-course of Ca 2+-induced insulin secretion from perifused, electrically permeabilised islets of Langerhans: effects of cAMP and a phorbol ester. Biochem Biophys Res Commun 1989; 162: 998-1003.
60. Thore S, Wuttke A, Tengholm A. Rapid turnover of phosphatidylinositol -4,5-bisphosphate in insulin-secreting cells mediated by Ca 2+ and the ATP-to-ADP ratio. Diabetes 2007; 56: 818-826.
61. Jones PM, Persaud SJ. Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic beta-cells. Endocr Rev 1998; 19: 429-461.
62. Robertson RP. Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis. Diabetes 1998; 47: 1379-1383.
63. Persaud SJ, Muller D, Belin VD, Papadimitriou A, Huang GC, Amiel SA, et al. Expression and function of cyclooxygenase and lipoxygenase enzymes in human islets of Langerhans. Arch Physiol Biochem 2007; 113: 104-109.
64. Tian YM, Urquidi V, Ashcroft SJ. Protein kinase C in beta-cells: expression of multiple isoforms and involvement in cholinergic stimulation of insulin secretion. Mol Cell Endocrinol 1996; 119: 185-193.
65. Biden TJ, Schmitz-Peiffer C, Burchfield JG, Gurisik E, Cantley J, Mitchell CJ, et al. The diverse roles of protein kinase C in pancreatic beta-cell function. Biochem Soc Trans 2008; 36: 916-919.
66. Szaszak M, Christian F, Rosenthal W, Klussmann E. Compartmentalized cAMP signalling in regulated exocytic processes in non-neuronal cells. Cell Signal 2008; 20: 590-601.
67. Persaud SJ, Jones PM, Howell SL. Glucose-stimulated insulin secretion is not dependent on activation of protein kinase A. Biochem Biophys Res Commun 1990; 173: 833-839.
68. Dyachok O, Idevall-Hagren O, Sagetorp J, Tian G, Wuttke A, Arrieumerlou C, et al. Glucose-induced cyclic AMP oscillations regulate pulsatile insulin secretion. Cell Metab 2008; 8: 26-37.
69. Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 2000; 49: 1751-1760.
70. Gembal M, Gilon P, Henquin JC. Evidence that glucose can control insulin release independently from its action on ATP-sensitive K + channels in mouse B cells. J Clin Invest 1992; 89: 1288-1295.
71. Ravier MA, Nenquin M, Miki T, Seino S, Henquin JC. Glucose controls cytosolic Ca 2+ and insulin secretion in mouse islets lacking adenosine triphosphate-sensitive K + channels owing to a knockout of the pore-forming subunit Kir6.2. Endocrinology 2009; 150: 33-45.
72. Detimary P, Gilon P, Nenquin M, Henquin JC. Two sites of glucose control of insulin release with distinct dependence on the energy state in pancreatic B-cells. Biochem J 1994; 297 (Part 3): 455-461.
73. Henquin JC, Meissner HP. Cyclic adenosine monophosphate differently affects the response of mouse pancreatic beta-cells to various amino acids. J Physiol 1986; 381: 77-93.
74. Minami K, Miki T, Kadowaki T, Seino S. Roles of ATP-sensitive K + channels as metabolic sensors: studies of Kir6.x null mice. Diabetes 2004; 53 (Suppl 3): S176-S180.
75. Muller D, Huang GC, Amiel S, Jones PM, Persaud SJ. Identification of insulin signaling elements in human beta-cells: autocrine regulation of insulin gene expression. Diabetes 2006; 55: 2835-2842.
76. Khan FA, Goforth PB, Zhang M, Satin LS. Insulin activates ATP-sensitive K + channels in pancreatic beta-cells through a phosphatidylinositol 3-kinase-dependent pathway. Diabetes 2001; 50: 2192-2198.
77. Zawalich WS, Zawalich KC. Effects of glucose, exogenous insulin, and carbachol on C-peptide and insulin secretion from isolated perifused rat islets. J Biol Chem 2002; 277: 26233-26237.
78. Leibiger B, Leibiger IB, Moede T, Kemper S, Kulkarni RN, Kahn CR, et al. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. Mol Cell 2001; 7: 559-570.
79. Muller D, Jones PM, Persaud SJ. Autocrine anti-apoptotic and proliferative effects of insulin in pancreatic beta-cells. FEBS Lett 2006; 580: 6977-6980.
80. Gromada J, Franklin I, Wollheim CB. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 2007; 28: 84-116.
81. Williams G, Bloom SR. Somatostatin and pancreatic polypeptide. In: Albert KGMM, DeFronzo RA, Keen H, Zimmett P, eds. International Textbook of Diabetes Mellitus. Chichester: Wiley, 1992; 341-355.
82. Holst JJ, Orskov C, Bersani M. Heterogeneity of islet hormones. In: Samols E, ed. The Endocrine Pancreas. New York: Raven Press, 1991; 125-152.
83. Vieira E, Salehi A, Gylfe E. Glucose inhibits glucagon secretion by a direct effect on mouse pancreatic alpha cells. Diabetologia 2007; 50: 370-379.
84. Kumar U, Sasi R, Suresh S, Patel A, Thangaraju M, Metrakos P, et al. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes 1999; 48: 77-85.
85. Strowski MZ, Parmar RM, Blake AD, Schaeffer JM. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology 2000; 141: 111-117.
86. Sharp GW. Mechanisms of inhibition of insulin release. Am J Physiol 1996; 271: C1781-C1799.
87. Nilsson T, Arkhammar P, Rorsman P, Berggren PO. Suppression of insulin release by galanin and somatostatin is mediated by a G-protein: an effect involving repolarization and reduction in cytoplasmic free Ca 2+ concentration. J Biol Chem 1989; 264: 973-980.
88. Degano P, Peiro E, Miralles P, Silvestre RA, Marco J. Effects of rat pancreatic polypeptide on islet-cell secretion in the perfused rat pancreas. Metabolism 1992; 41: 306-309.
89. Wierup N, Svensson H, Mulder H, Sundler F. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept 2002; 107: 63-69.
90. Andralojc KM, Mercalli A, Nowak KW, Albarello L, Calcagno R, Luzi L, et al. Ghrelin-producing epsilon cells in the developing and adult human pancreas. Diabetologia 2009; 52: 486-493.
91. Dezaki K, Sone H, Yada T. Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol Ther 2008; 118: 239-249.
92. Gentes M. Note sur les terminaisons nerveuses des islots de Langerhans du pancreas. Soc Biol 1902; 54: 202-203.
93. Gilon P, Henquin JC. Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr Rev 2001; 22: 565-604.
94. Porte D Jr, Seeley RJ, Woods SC, Baskin DG, Figlewicz DP, Schwartz MW. Obesity, diabetes and the central nervous system. Diabetologia 1998; 41: 863-881.
95. Iismaa TP, Kerr EA, Wilson JR, Carpenter L, Sims N, Biden TJ. Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. Diabetes 2000; 49: 392-398.
96. Ahren B, Lundquist I. Effects of selective and non-selective beta-adrenergic agents on insulin secretion in vivo. Eur J Pharmacol 1981; 71: 93-104.
97. Morgan NG, Chan SL, Lacey RJ, Brown CA. Pharmacology and molecular biology of islet cell adrenoceptors. In: Flatt PR, Lenzen S, eds. Frontiers of Insulin Secretion and Pancreatic B-cell Research. London: Smith-Gordon, 1994; 359-368.
98. Lacey RJ, Berrow NS, London NJ, Lake SP, James RF, Scarpello JH, et al. Differential effects of beta-adrenergic agonists on insulin secretion from pancreatic islets isolated from rat and man. J Mol Endocrinol 1990; 5: 49-54.
99. Kuo WN, Hodgins DS, Kuo JF. Adenylate cyclase in islets of Langerhans: isolation of islets and regulation of adenylate cyclase activity by various hormones and agents. J Biol Chem 1973; 248: 2705-2711.
100. Yamazaki S, Katada T, Ui M. Alpha 2-adrenergic inhibition of insulin secretion via interference with cyclic AMP generation in rat pancreatic islets. Mol Pharmacol 1982; 21: 648-653.
101. Jones PM, Fyles JM, Persaud SJ, Howell SL. Catecholamine inhibition of Ca 2+-induced insulin secretion from electrically permeabilised islets of Langerhans. FEBS Lett 1987; 219: 139-144.
102. Winzell MS, Ahren B. G-protein-coupled receptors and islet function -implications for treatment of type 2 diabetes. Pharmacol Ther 2007; 116: 437-448.
103. Wahl MA, Straub SG, Ammon HP. Vasoactive intestinal polypeptide -augmented insulin release: actions on ionic fluxes and electrical activity of mouse islets. Diabetologia 1993; 36: 920-925.
104. Straub SG, Sharp GW. Mechanisms of action of VIP and PACAP in the stimulation of insulin release. Ann N Y Acad Sci 1996; 805: 607-612.
105. Wahl MA, Plehn RJ, Landsbeck EA, Verspohl EJ, Ammon HP. Gastrin releasing peptide augments glucose mediated 45Ca 2+ uptake, electrical activity, and insulin secretion of mouse pancreatic islets. Endocrinology 1991; 128: 3247-3252.
106. Dunning BE, Ahren B, Veith RC, Bottcher G, Sundler F, Taborsky GJ Jr. Galanin: a novel pancreatic neuropeptide. Am J Physiol 1986; 251: E127-E133.
107. Moltz JH, McDonald JK. Neuropeptide Y: direct and indirect action on insulin secretion in the rat. Peptides 1985; 6: 1155-1159.
108. Morgan DG, Kulkarni RN, Hurley JD, Wang ZL, Wang RM, Ghatei MA, et al. Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells. Diabetologia 1998; 41: 1482-1491.
109. Cormont M, Le Marchand-Brustel Y, van OE, Spiegel AM, Sharp GW. Identification of G protein alpha-subunits in RINm5F cells and their selective interaction with galanin receptor. Diabetes 1991; 40: 1170-1176.
110. McIntyre N, Holdsworth CD, Turner DS. New interpretation of oral glucose tolerance. Lancet 1964; 2: 20-21.
111. Drucker DJ. The role of gut hormones in glucose homeostasis. J Clin Invest 2007; 117: 24-32.
112. Karhunen LJ, Juvonen KR, Huotari A, Purhonen AK, Herzig KH. Effect of protein, fat, carbohydrate and fibre on gastrointestinal peptide release in humans. Regul Pept 2008; 149: 70-78.
113. Kieffer TJ, Habener JF. The glucagon-like peptides. Endocr Rev 1999; 20: 876-913.
114. Drucker DJ, Nauck MA. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006; 368: 1696-1705.
115. Kolterman OG, Kim DD, Shen L, Ruggles JA, Nielsen LL, Fineman MS, et al. Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus. Am J Health Syst Pharm 2005; 62: 173-181.
116. Suga S, Kanno T, Ogawa Y, Takeo T, Kamimura N, Wakui M. cAMP-independent decrease of ATP-sensitive K + channel activity by GLP-1 in rat pancreatic beta-cells. Pflugers Arch 2000; 440: 566-572.
117. Ehses JA, Lee SS, Pederson RA, McIntosh CH. A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion. J Biol Chem 2001; 276: 23667-23673.
118. Chia CW, Carlson OD, Kim W, Shin YK, Charles CP, Kim HS, et al. Exogenous glucose-dependent insulinotropic polypeptide worsens post-prandial hyperglycemia in type 2 diabetes. Diabetes 2009; 58: 1342-1349.
119. Morgan LM. The entero-insular axis. Biochem Soc Trans 1980; 8: 17-19.
120. Persaud SJ, Jones PM, Howell SL. Stimulation of insulin secretion by cholecystokinin-8S: the role of protein kinase C. Pharmacol Commun 1993; 3: 39-47.
121. Catalan V, Gomez-Ambrosi J, Rodriguez A, Salvador J, Fruhbeck G. Adipokines in the treatment of diabetes mellitus and obesity. Expert Opin Pharmacother 2009; 10: 239-254.
122. Cases JA, Gabriely I, Ma XH, Yang XM, Michaeli T, Fleischer N, et al. Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes 2001; 50: 348-352.
123. Morioka T, Asilmaz E, Hu J, Dishinger JF, Kurpad AJ, Elias CF, et al. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest 2007; 117: 2860-2868.
124. Kieffer TJ, Heller RS, Leech CA, Holz GG, Habener JF. Leptin suppression of insulin secretion by the activation of ATP-sensitive K + channels in pancreatic beta-cells. Diabetes 1997; 46: 1087-1093.
125. Maedler K, Schulthess FT, Bielman C, Berney T, Bonny C, Prentki M, et al. Glucose and leptin induce apoptosis in human beta-cells and impair glucose-stimulated insulin secretion through activation of c-Jun N-terminal kinases. FASEB J 2008; 22: 1905-1913.
126. Nakata M, Okada T, Ozawa K, Yada T. Resistin induces insulin resistance in pancreatic islets to impair glucose-induced insulin release. Biochem Biophys Res Commun 2007; 353: 1046-1051.
127. Gao CL, Zhao DY, Qiu J, Zhang CM, Ji CB, Chen XH, et al. Resistin induces rat insulinoma cell RINm5F apoptosis. Mol Biol Rep 2009; 36: 1703-1708.
128. Arner P. Resistin: yet another adipokine tells us that men are not mice. Diabetologia 2005; 48: 2203-2205.
129. Minn AH, Patterson NB, Pack S, Hoffmann SC, Gavrilova O, Vinson C, et al. Resistin is expressed in pancreatic islets. Biochem Biophys Res Commun 2003; 310: 641-645.
130. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595-1599.
131. Gu W, Li X, Liu C, Yang J, Ye L, Tang J, et al. Globular adiponectin augments insulin secretion from pancreatic islet beta cells at high glucose concentrations. Endocrine 2006; 30: 217-221.
132. Okamoto M, Ohara-Imaizumi M, Kubota N, Hashimoto S, Eto K, Kanno T, et al. Adiponectin induces insulin secretion in vitro and in vivo at a low glucose concentration. Diabetologia 2008; 51: 827-835.
133. Rakatzi I, Mueller H, Ritzeler O, Tennagels N, Eckel J. Adiponectin counteracts cytokine-and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia 2004; 47: 249-258.